Your session is about to expire
← Back to Search
RegeneCyte for Post-COVID Syndrome
Study Summary
This trial will test if using stem cells from cord blood or umbilical cord can help patients who have long-term effects from COVID.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You need to have a negative COVID-19 test taken within the last 7 days.I have not had any vaccinations in the last 3 weeks.I had a neurological disorder before getting COVID-19.You may have medical conditions that could make the study risky, as determined by the doctor.I am 18 years old or older.I am experiencing long-term effects after recovering from COVID-19.You have a known immune system disorder.You have a serious illness that cannot be cured.
- Group 1: RegeneCyte
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the RegeneCyte therapeutic option officially endorsed by the FDA?
"While the efficacy of RegeneCyte has yet to be determined, there is some existing evidence that suggests a certain degree of safety. Thus, it was awarded a score of 2 on our rating scale."
Who possesses the necessary qualifications to participate in this clinical trial?
"To be considered for enrolment, participants must have been diagnosed with post-covid syndrome and should fall between the ages of 18 and 80. The study team hopes to recruit a total of 30 patients."
Are participants aged 25 and over eligible to join this clinical trial?
"Participants of this trial must be 18 to 80 years old. If the patient is younger than 18, there are 370 other trials they can qualify for; if older than 65, 978 studies may still apply."
Is this experiment currently seeking participants?
"The details provided on clinicaltrials.gov suggest that, as of 1/11/2023, this study is not looking for patients to take part in the trial. This investigation was initially posted on 3/1/2023 and has since been revised; however, 1388 other studies are currently recruiting participants."
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger